Ticker Symbol: NERV

Minerva Neurosciences Inc

$1.32 - 17-09-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001598646

Company Profile

Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson's disease.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: 1601 Trapelo Rd Ste 286

Website: www.minervaneurosciences.com

CEO: Remy Luthringer

Tags:

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $6.70

Change: $0.01 ( 0.15%)

Days Range: $6.52 - $6.83

Beta: 1.51

52wk. High: $13.22

52wk. Low: $1.26

Ytd. Change 320.90%

50 Day Moving Average: $7.08

200 Day Moving Average: $7.07

Shares Outstanding: 6993406

Valuation

Market Cap: 4.7B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A